Paclitaxel

phosphoglycolate phosphatase ; Homo sapiens







93 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34979464 Design, synthesis and SAR study of Fluorine-containing 3rd-generation taxoids. 2022 Feb 1
2 35173861 Apatinib inhibits paclitaxel resistance of gastric carcinoma cells through VEGFR2 pathway. 2022 1
3 35623257 Laser-responsive multi-functional nanoparticles for efficient combinational chemo-photodynamic therapy against breast cancer. 2022 Aug 2
4 33049093 Esomeprazole overcomes paclitaxel-resistance and enhances anticancer effects of paclitaxel by inducing autophagy in A549/Taxol cells. 2021 Jan 1
5 33513992 Hyaluronic Acid-Targeted Stimuli-Sensitive Nanomicelles Co-Encapsulating Paclitaxel and Ritonavir to Overcome Multi-Drug Resistance in Metastatic Breast Cancer and Triple-Negative Breast Cancer Cells. 2021 Jan 27 1
6 33691261 Therapeutic strategies to overcome taxane resistance in cancer. 2021 Mar 1
7 33758505 Synergistic Inhibition of Drug-Resistant Colon Cancer Growth with PI3K/mTOR Dual Inhibitor BEZ235 and Nano-Emulsioned Paclitaxel via Reducing Multidrug Resistance and Promoting Apoptosis. 2021 1
8 33804018 Characterization of P-Glycoprotein Inhibitors for Evaluating the Effect of P-Glycoprotein on the Intestinal Absorption of Drugs. 2021 Mar 15 1
9 34413359 Structure activity relationships and the binding mode of quinolinone-pyrimidine hybrids as reversal agents of multidrug resistance mediated by P-gp. 2021 Aug 19 1
10 31783010 Overcoming Taxol-resistance in A549 cells: A comprehensive strategy of targeting P-gp transporter, AKT/ERK pathways, and cytochrome P450 enzyme CYP1B1 by 4-hydroxyemodin. 2020 Jan 1
11 32897218 [Long-chain non-coding RNA MALAT1 regulates paclitaxel resistance of breast cancer cells by targeting miR-485-3p]. 2020 May 30 2
12 30292104 Tannic acid-inspired paclitaxel nanoparticles for enhanced anticancer effects in breast cancer cells. 2019 Feb 1 1
13 30367323 Chemotherapy in pregnancy: exploratory study of the effects of paclitaxel on the expression of placental drug transporters. 2019 Oct 3
14 30431082 ERp57‑small interfering RNA silencing can enhance the sensitivity of drug‑resistant human ovarian cancer cells to paclitaxel. 2019 Jan 1
15 30530177 Basic principles of drug delivery systems - the case of paclitaxel. 2019 Jan 1
16 30540465 Probing the Pharmacological Binding Sites of P-Glycoprotein Using Umbrella Sampling Simulations. 2019 May 28 1
17 30556139 Effect of endogenous multidrug resistance 1 and P-glycoprotein expression on anticancer drug resistance in colon cancer cell lines. 2019 Jan 2
18 30600025 Self-assembled micelles based on N-octyl-N'-phthalyl-O-phosphoryl chitosan derivative as an effective oral carrier of paclitaxel. 2019 Mar 1 2
19 30959904 Cytotoxic Effect of Paclitaxel and Lapatinib Co-Delivered in Polylactide-co-Poly(ethylene glycol) Micelles on HER-2-Negative Breast Cancer Cells. 2019 Apr 6 1
20 31536779 In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures. 2019 Dec 1 1
21 31875434 [Role of protein kinase D1 in regulating the growth, apoptosis and drug sensitivity of oral squamous carcinoma cells]. 2019 Dec 1 1
22 29253998 N-mercapto acetyl-N'-octyl-O, N″-glycol chitosan as an efficiency oral delivery system of paclitaxel. 2018 Feb 1 1
23 29439899 High expression of class III β-tubulin has no impact on functional cancer cell growth inhibition of a series of key vinblastine analogs. 2018 Mar 1 2
24 29683800 Generation and characterization of a paclitaxel-resistant human gastric carcinoma cell line. 2018 Jul 2
25 30251669 Nitric oxide reverses drug resistance by inhibiting ATPase activity of p-glycoprotein in human multi-drug resistant cancer cells. 2018 Dec 1
26 30308274 Self-assembly of biotinylated poly(ethylene glycol)-poly(curcumin) for paclitaxel delivery. 2018 Dec 20 1
27 30444601 Hydrogen-Bonded Tannic Acid-Based Anticancer Nanoparticle for Enhancement of Oral Chemotherapy. 2018 Dec 12 1
28 27750197 Extending the structure-activity relationship study of marine natural ningalin B analogues as P-glycoprotein inhibitors. 2017 Jan 5 1
29 28253574 [Reverse of the resistance to paclitaxel of the heparin binding-epidermal growth factor-like growth factor inhibitor in ovarian cancer]. 2017 Feb 25 4
30 28441715 Targeting the Bcl-2 family and P-glycoprotein reverses paclitaxel resistance in human esophageal carcinoma cell line. 2017 Jun 3
31 26820614 Human-Mouse Chimeras with Normal Expression and Function Reveal That Major Domain Swapping Is Tolerated by P-Glycoprotein (ABCB1). 2016 Feb 23 2
32 26900771 Cell-Penetrating, Guanidinium-Rich Oligophosphoesters: Effective and Versatile Molecular Transporters for Drug and Probe Delivery. 2016 Mar 16 2
33 27262378 Ferulic acid reverses ABCB1-mediated paclitaxel resistance in MDR cell lines. 2016 Sep 5 1
34 27301180 The Effect of Surfactant on Paclitaxel Nanocrystals: An In Vitro and In Vivo Study. 2016 Jan 1
35 27304668 Glaucarubinone sensitizes KB cells to paclitaxel by inhibiting ABC transporters via ROS-dependent and p53-mediated activation of apoptotic signaling pathways. 2016 Jul 5 1
36 27664577 Characterization of acquired paclitaxel resistance of breast cancer cells and involvement of ABC transporters. 2016 Nov 1 1
37 27763524 Characterization, in Vivo and in Vitro Evaluation of Solid Dispersion of Curcumin Containing d-α-Tocopheryl Polyethylene Glycol 1000 Succinate and Mannitol. 2016 Oct 17 2
38 27863655 Direct in vivo evidence on the mechanism by which nanoparticles facilitate the absorption of a water insoluble, P-gp substrate. 2016 Nov 30 1
39 25677062 NSC23925 prevents the emergence of multidrug resistance in ovarian cancer in vitro and in vivo. 2015 Apr 2
40 25904021 Nsc23925 prevents the development of paclitaxel resistance by inhibiting the introduction of P-glycoprotein and enhancing apoptosis. 2015 Oct 15 1
41 26076081 IF7-Conjugated Nanoparticles Target Annexin 1 of Tumor Vasculature against P-gp Mediated Multidrug Resistance. 2015 Aug 19 1
42 26144859 Novel dietary lipid-based self-nanoemulsifying drug delivery systems of paclitaxel with p-gp inhibitor: implications on cytotoxicity and biopharmaceutical performance. 2015 1
43 26233798 Optimization of permethyl ningalin B analogs as P-glycoprotein inhibitors. 2015 Sep 1 1
44 26265061 Investigating the role of Pluronic-g-Cationic polyelectrolyte as functional stabilizer for nanocrystals: Impact on Paclitaxel oral bioavailability and tumor growth. 2015 Oct 2
45 26514453 Enhancing Activity of Anticancer Drugs in Multidrug Resistant Tumors by Modulating P-Glycoprotein through Dietary Nutraceuticals. 2015 1
46 26536707 [The effect of MDR1 (P-gp) and ABCG2 on the drug resistance in Hep 2 cells]. 2015 Jun 2
47 24239580 Improvement of cellular uptake, in vitro antitumor activity and sustained release profile with increased bioavailability from a nanoemulsion platform. 2014 Jan 2 1
48 24805866 Role and mechanism of Twist1 in modulating the chemosensitivity of FaDu cells. 2014 Jul 1
49 24866272 A TPGS-incorporating nanoemulsion of paclitaxel circumvents drug resistance in breast cancer. 2014 Aug 25 1
50 24927684 Amphiphilic carboxymethyl chitosan-quercetin conjugate with P-gp inhibitory properties for oral delivery of paclitaxel. 2014 Aug 1